Ibritumomab, also Zevalin, represents the innovative form of targeted radiotherapy employed to combat certain types of cancers, particularly previously treated lymphomas. It is a monoclonal molecule https://ronaldaoyj679424.blog5.net/92148947/ibritumomab-a-detailed-examination-into-the-specific-cancer-approach